AR and breast cancer: A study by Robinson et al. showed that about 98% of AR binding to DNA events overlapped with the FoxA1-binding region in the molecular apocrine MDA-MB-453 breast cancer cell line, leading to the suggestion that all AR transcriptional activity in molecular apocrine breast cancer cells might be mediated by FoxA1 [82].